BioHarvest Sciences Inc. (OTCPK: CNVCF) (CSE: BHSC) (FSE:8MV) announced a financing plan based on a private placement of up to $5 million. The funds raised will allow the company to accelerate the growth plan for its polyphenols/antioxidants and cannabis verticals.
BioHarvest Sciences Inc.'s (OTCPK: CNVCF) (CSE: BHSC) (FSE:8MV) sales of its flagship VINIA product in Q1 2022 reached $787K, representing 112% growth compared to the same quarter of last year.